跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Nostero
Approved
STANDARD
Nostero
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6d192d6fa640bb25
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
6d192d6fa640bb25
Drug Approval Philippines Name
Nostero
Product Name
Nostero
Registration Number
DR-XY27059
Brand Name
Nostero
Generic Name
Phenylpropanolamine Hydrochloride/Brompheniramine Maleate
Dosage Form
Syrup
Dosage Strength
12.5 mg/4 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
J.M. Tolmann Laboratories, Inc.
Issuance Date
25 June 2021
Expiry Date
09 July 2026
Pharmacologic Category
Decongestant / Anthistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6d192d6fa640bb25
Type
Standard
Back to Philippines FDA Approvals
Nostero - Philippines FDA Drug Approval Details